Press
Records 21 to 30 of 50
6/29/2005 7:00:00 AM
Ingen Technologies Announces the Acquisition of Land and Patents-The Company increases its assets by $2M-
Calimesa, CA- June 29, 2005 for 7:00AM EST: Ingen Technologies (OTC: IGTN), a medical device manufacturer of OxyAlert™ and Secure Balance™ has announced the acquisition of 2 acres of land in Pitsgrove, New Jersey and two medical technology patents.
6/21/2005 7:00:00 AM
Ingen Technologies Prepares To Launch OxyAlert™ - OxyAlert™ will impact $45M in sales first part of next year
Calimesa, CA- June 21, 2005 for 7:00AM EST: Ingen Technologies (OTC: IGTN), a medical device manufacturer for physicians and consumer markets, announced today that OxyAlert™ would be ready by January 1, 2006.
6/15/2005 7:00:00 AM
Ingen Technologies Launches Secure Balance™ Commercial
Calimesa, CA- June 15, 2005 for 7:00AM EST: Ingen Technologies (OTC: IGTN), a medical device manufacturer for physicians and consumer markets, announced today that with the cooperation of the Southeastern Neuroscience Institute, Inc. and Preferred Provider Care, Inc., a television commercial is scheduled for release in the State of Florida.
6/14/2005 7:00:00 AM
Ingen Technologies Reports Record Sales and Earnings - The Company Announces It Is Now Debt Free
Calimesa, CA- June 14, 2005 for 7:00AM EST: Ingen Technologies (OTC: IGTN), a medical device manufacturer for physicians and consumer markets, announced today that the financial audits are ready for filing. Ingen Technologies, Inc. reports income for the 2004 fiscal year to be approximately $1 million dollars, bringing in $285,000.00 of profits. IGTN is also proud to announce that the income for the first 2 quarters of 2005 to be approximately $ 700,000.00, already toppling the income of the previous year.
6/8/2005 7:00:00 AM
Ingen Tecnologies Prepares to Strengthen Market Value for Its Shareholders and Investors
Calimesa, CA- June 8, 2005 for 7:00AM EST: Ingen Technologies (OTC: IGTN), a medical device manufacturer for physicians and consumer markets, announced today the finalization of Agreements with C-TradeUSA, Inc.
5/24/2005 7:30:00 AM
Ingen Technologies to Enter Multi-Trillion Dollar Organic Produce Market - Expands New Facilities on East and West Coasts
Calimesa, CA- May 24, 2005 for 7:30AM EST: Ingen Technologies (OTC: IGTN), a medical device manufacturer and service provider for medical and consumer markets, announced today the expansion of two more offices in order to manage growth demands.
5/12/2005 10:00:00 AM
Ingen Technologies Enters Potential $400 Million Neurology Market
Ingen Technologies (OTC: IGTN), a medical device manufacturer and service provider for medical and consumer markets, announced today that the Secure Balance™ products created sales of over $400,000 at the neurology annual meeting in Miami, indicating how successfully members of the American Academy of Neurology accepted Secure Balance™.
3/24/2005 8:15:00 AM
Ingen Technologies Exhibits Product Line at the American Academy of Neurology
Jacob Green, MD, President and Founder of the Southeastern Neuroscience Institute stated: “The American Academy of Neurology has 14,000 members. At least 2,000 shall arrive in Miami and be there to take courses and find out what the newest equipment is and how to provide better services for patient care. The Secure Balance™ product line is superior to any other product line in the industry, and it is exclusively endorsed by our Foundation and the American Academy of Balance Medicine.”
2/23/2005 9:04:00 AM
Ingen Technologies Enjoys Revenue Jump - Secure Balance™ Sales Skyrocket
Calimesa, CA- February 23, 2005: Ingen Technologies (OTC: IGTN), a medical device manufacturer and service provider for medical and consumer markets, announced today that it has received $250,000 in Secure Balance™ orders in the past 7 days, with pending orders of $550,000 for March.
2/1/2005 9:00:00 AM
Ingen Technologies to Launch Its Second Generation OxyAlert™ --Marketing to generate $30 million in first 18 months of production--
Calimesa, CA- February 1, 2005: Ingen Technologies (OTC: IGTN), a medical device manufacturer and service provider for medical and consumer markets, announced today that it has received approval to complete the final phase of development for OxyALERT™, the Company’s flagship product. Over $4 million has been invested in the development of OxyALERT since 2003.
| << First | < Previous | Next > | Last >> |
|---|
